Home Recalls D-0259-2022
Class II · Moderate risk Terminated Initiated Oct 19, 2021 (5 years ago)
Diclofenac Sodium Topical Solution USP, 1.5 w/w, 5 fl oz (150 mL) plastic bottles, Rx…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Defective Container
What was recalled
Diclofenac Sodium Topical Solution USP, 1.5 w/w, 5 fl oz (150 mL) plastic bottles, Rx only, Teligent Pharma, Inc., Buena, New Jersey, 08310, NDC 70512-025-05.
Recalling firm Teligent Pharma, Inc.
NDC code 70512-025-05
Origin NJ, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0259-2022
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing Jan 27, 2026
Reason Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
Class III · Low risk Ongoing Dec 22, 2025
Reason Failed PH Specifications
Class II · Moderate risk Ongoing Jun 22, 2023
Reason Defective Delivery System
Class II · Moderate risk Terminated Mar 24, 2022
Reason CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability…
Class II · Moderate risk Terminated Mar 15, 2022
Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.